164 related articles for article (PubMed ID: 23182475)
1. Induction of double ovulation in mares using deslorelin acetate.
Nagao JF; Neves Neto JR; Papa FO; Alvarenga MA; Freitas-Dell'Aqua CP; Dell'Aqua JA
Anim Reprod Sci; 2012 Dec; 136(1-2):69-73. PubMed ID: 23182475
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of eFSH and deslorelin treatment regimes on ovarian stimulation and embryo production of donor mares in early vernal transition.
Raz T; Carley S; Card C
Theriogenology; 2009 Jun; 71(9):1358-66. PubMed ID: 19329174
[TBL] [Abstract][Full Text] [Related]
3. Deslorelin on Day 8 or 12 postovulation does not luteinize follicles during an artificially maintained diestrous phase in the mare.
Glazar BS; McCue PM; Bruemmer JE; Squires EL
Theriogenology; 2004 Jul; 62(1-2):57-64. PubMed ID: 15159101
[TBL] [Abstract][Full Text] [Related]
4. Interovulatory intervals in mares receiving deslorelin implants in Ireland (2009 to 2010).
Henderson IS; Brama P; Osborne M; Beltman ME
Vet Rec; 2012 May; 170(21):541. PubMed ID: 22535750
[TBL] [Abstract][Full Text] [Related]
5. Effect of deslorelin acetate on gonadotropin secretion and ovarian follicle development in cycling mares.
Farquhar VJ; McCue PM; Nett TM; Squires EL
J Am Vet Med Assoc; 2001 Mar; 218(5):749-52. PubMed ID: 11280410
[TBL] [Abstract][Full Text] [Related]
6. Pituitary responsiveness to GnRH in mares following deslorelin acetate implantation to hasten ovulation.
Johnson CA; Thompson DL; Cartmill JA
J Anim Sci; 2002 Oct; 80(10):2681-7. PubMed ID: 12413091
[TBL] [Abstract][Full Text] [Related]
7. Treatment with recombinant equine follicle stimulating hormone (reFSH) followed by recombinant equine luteinizing hormone (reLH) increases embryo recovery in superovulated mares.
Meyers-Brown G; Bidstrup LA; Famula TR; Colgin M; Roser JF
Anim Reprod Sci; 2011 Oct; 128(1-4):52-9. PubMed ID: 22005252
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of BioRelease Deslorelin® injection for induction of ovulation in oestrus mares: a field study.
Finan SA; Lamkin EL; McKinnon AO
Aust Vet J; 2016 Sep; 94(9):338-40. PubMed ID: 27569838
[TBL] [Abstract][Full Text] [Related]
9. Effects of a new injectable short-term release deslorelin in foal-heat mares.
Stich KL; Wendt KM; Blanchard TL; Brinsko SP
Theriogenology; 2004 Sep; 62(5):831-6. PubMed ID: 15251234
[TBL] [Abstract][Full Text] [Related]
10. Successful timing of ovulation using deslorelin (Ovuplant) is labour-saving in mares aimed for single ai with frozen semen.
Hemberg E; Lundeheim N; Einarsson S
Reprod Domest Anim; 2006 Dec; 41(6):535-7. PubMed ID: 17107513
[TBL] [Abstract][Full Text] [Related]
11. Does Clinical Treatment with Phenylbutazone and Meloxicam in the Pre-ovulatory Period Influence the Ovulation Rate in Mares?
Lima AG; Costa LC; Alvarenga MA; Martins CB
Reprod Domest Anim; 2015 Oct; 50(5):771-5. PubMed ID: 26280558
[TBL] [Abstract][Full Text] [Related]
12. Reproductive performance of donor mares subsequent to eFSH treatment in early vernal transition: Comparison between the first, second, and mid-season estrous cycles of the breeding season.
Raz T; Hunter B; Carley S; Card C
Anim Reprod Sci; 2009 Nov; 116(1-2):107-18. PubMed ID: 19171444
[TBL] [Abstract][Full Text] [Related]
13. Use of the GnRH analogue, deslorelin acetate, in a slow-release implant to accelerate ovulation in oestrous mares.
Meyers PJ; Bowman T; Blodgett G; Conboy HS; Gimenez T; Reid MP; Taylor BC; Thayer J; Jöchle W; Trigg TE
Vet Rec; 1997 Mar; 140(10):249-52. PubMed ID: 9080642
[TBL] [Abstract][Full Text] [Related]
14. Use of a low dose of equine purified FSH to induce multiple ovulations in mares.
Araujo GH; Rocha Filho AN; Lopes EP; Moya CF; Alvarenga MA
Reprod Domest Anim; 2009 Jun; 44(3):380-3. PubMed ID: 18673335
[TBL] [Abstract][Full Text] [Related]
15. Effects of deslorelin or hCG administration on reproductive performance in first postpartum estrus mares.
Blanchar TL; Brinsko SP; Rigby SL
Theriogenology; 2002 Jul; 58(1):165-9. PubMed ID: 12182359
[TBL] [Abstract][Full Text] [Related]
16. Deslorelin acetate (Ovuplant) therapy in cycling mares: effect of implant removal on FSH secretion and ovarian function.
Farquhar VJ; McCue PM; Carnevale EM; Nett TM; Squires EL
Equine Vet J; 2002 Jul; 34(4):417-20. PubMed ID: 12117117
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of recombinant equine follicle stimulating hormone (reFSH) to promote follicular growth in mares using a follicular suppression model.
Jennings MW; Boime I; Daphna-Iken D; Jablonka-Shariff A; Conley AJ; Colgin M; Bidstrup LA; Meyers-Brown GA; Famula TR; Roser JF
Anim Reprod Sci; 2009 Dec; 116(3-4):291-307. PubMed ID: 19237253
[TBL] [Abstract][Full Text] [Related]
18. Expression of angiogenic factors and luteinizing hormone receptors in the corpus luteum of mares induced to ovulate with deslorelin acetate.
Maia VN; Batista AM; Cunha Neto S; Silva DM; Adrião M; Wischral A
Theriogenology; 2016 Feb; 85(3):461-5. PubMed ID: 26476595
[TBL] [Abstract][Full Text] [Related]
19. Effects of deslorelin acetate implants in horses: single implants in stallions and steroid-treated geldings and multiple implants in mares.
Johnson CA; Thompson DL; Cartmill JA
J Anim Sci; 2003 May; 81(5):1300-7. PubMed ID: 12772858
[TBL] [Abstract][Full Text] [Related]
20. Repeatability of preovulatory follicular diameter and uterine edema pattern in two consecutive cycles in the mare and how they are influenced by ovulation inductors.
Cuervo-Arango J; Newcombe JR
Theriogenology; 2008 Apr; 69(6):681-7. PubMed ID: 18242672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
